These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 37842128)

  • 1. Clinical Insight on Proton Therapy for Paediatric Rhabdomyosarcoma.
    Vennarini S; Colombo F; Mirandola A; Chiaravalli S; Orlandi E; Massimino M; Casanova M; Ferrari A
    Cancer Manag Res; 2023; 15():1125-1139. PubMed ID: 37842128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton Therapy in Non-Rhabdomyosarcoma Soft Tissue Sarcomas of Children and Adolescents.
    Vennarini S; Colombo F; Mirandola A; Orlandi E; Pecori E; Chiaravalli S; Massimino M; Casanova M; Ferrari A
    Cancers (Basel); 2024 Apr; 16(9):. PubMed ID: 38730646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of failure following proton beam therapy for head and neck rhabdomyosarcoma.
    Ludmir EB; Grosshans DR; McAleer MF; McGovern SL; Harrison DJ; Okcu MF; Chintagumpala MM; Mahajan A; Paulino AC
    Radiother Oncol; 2019 May; 134():143-150. PubMed ID: 31005208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tailor-made treatment combined with proton beam therapy for children with genitourinary/pelvic rhabdomyosarcoma.
    Fukushima H; Fukushima T; Sakai A; Suzuki R; Kobayashi C; Oshiro Y; Mizumoto M; Hoshino N; Gotoh C; Urita Y; Komuro H; Kaneko M; Sekido N; Masumoto K; Sakurai H; Sumazaki R
    Rep Pract Oncol Radiother; 2015; 20(3):217-22. PubMed ID: 25949226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Worse Outcomes for Head and Neck Rhabdomyosarcoma Secondary to Reduced-Dose Cyclophosphamide.
    Casey DL; Wexler LH; Wolden SL
    Int J Radiat Oncol Biol Phys; 2019 Apr; 103(5):1151-1157. PubMed ID: 30508617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of failure and toxicity profile following proton beam therapy for pediatric bladder and prostate rhabdomyosarcoma.
    Buszek SM; Ludmir EB; Grosshans DR; McAleer MF; McGovern SL; Harrison DJ; Okcu MF; Chintagumpala MM; Mahajan A; Paulino AC
    Pediatr Blood Cancer; 2019 Nov; 66(11):e27952. PubMed ID: 31397065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skin Toxicity Profile of Photon Radiotherapy versus Proton Beam Therapy in Paediatric and Young Adult Patients with Sarcomas.
    Gaito S; Abravan A; Richardson J; Lowe M; Indelicato DJ; Burnet N; Smith E
    Clin Oncol (R Coll Radiol); 2021 Aug; 33(8):507-516. PubMed ID: 33820695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of Patients Treated in the UK Proton Overseas Programme: Non-central Nervous System Group.
    Hwang E; Gaito S; France A; Crellin AM; Thwaites DI; Ahern V; Indelicato D; Timmermann B; Smith E
    Clin Oncol (R Coll Radiol); 2023 May; 35(5):292-300. PubMed ID: 36813694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease Control and Patterns of Failure After Proton Beam Therapy for Rhabdomyosarcoma.
    Buszek SM; Ludmir EB; Grosshans DR; McAleer MF; McGovern SL; Harrison DJ; Okcu MF; Chintagumpala MM; Mahajan A; Paulino AC
    Int J Radiat Oncol Biol Phys; 2021 Mar; 109(3):718-725. PubMed ID: 33516439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton radiotherapy for pediatric bladder/prostate rhabdomyosarcoma: clinical outcomes and dosimetry compared to intensity-modulated radiation therapy.
    Cotter SE; Herrup DA; Friedmann A; Macdonald SM; Pieretti RV; Robinson G; Adams J; Tarbell NJ; Yock TI
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1367-73. PubMed ID: 20934266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A dosimetric comparison of proton and intensity-modulated photon radiotherapy for pediatric parameningeal rhabdomyosarcomas.
    Kozak KR; Adams J; Krejcarek SJ; Tarbell NJ; Yock TI
    Int J Radiat Oncol Biol Phys; 2009 May; 74(1):179-86. PubMed ID: 19019562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normal Tissue Complication Probability Modelling for Toxicity Prediction and Patient Selection in Proton Beam Therapy to the Central Nervous System: A Literature Review.
    Gaito S; Burnet N; Aznar M; Crellin A; Indelicato DJ; Ingram S; Pan S; Price G; Hwang E; France A; Smith E; Whitfield G
    Clin Oncol (R Coll Radiol); 2022 Jun; 34(6):e225-e237. PubMed ID: 35042622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton Therapy in Non-small Cell Lung Cancer.
    Mesko S; Gomez D
    Curr Treat Options Oncol; 2018 Nov; 19(12):76. PubMed ID: 30483900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton radiotherapy for orbital rhabdomyosarcoma: clinical outcome and a dosimetric comparison with photons.
    Yock T; Schneider R; Friedmann A; Adams J; Fullerton B; Tarbell N
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1161-8. PubMed ID: 15950401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton radiotherapy for parameningeal rhabdomyosarcoma: clinical outcomes and late effects.
    Childs SK; Kozak KR; Friedmann AM; Yeap BY; Adams J; MacDonald SM; Liebsch NJ; Tarbell NJ; Yock TI
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):635-42. PubMed ID: 21377294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complete second look operation and radiotherapy in locally advanced non-alveolar rhabdomyosarcoma in children: A report from the AIEOP soft tissue sarcoma committee.
    Cecchetto G; Carretto E; Bisogno G; Dall'Igna P; Ferrari A; Scarzello G; Donfrancesco A; Alaggio R; Indolfi P; Carli M
    Pediatr Blood Cancer; 2008 Nov; 51(5):593-7. PubMed ID: 18668515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton beam therapy with concurrent chemotherapy is feasible in children with newly diagnosed rhabdomyosarcoma.
    Suzuki R; Fukushima H; Okuwaki H; Inaba M; Hosaka S; Yamaki Y; Fukushima T; Masumoto K; Mizumoto M; Sakurai H; Takada H
    Rep Pract Oncol Radiother; 2021; 26(4):616-625. PubMed ID: 34434578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pencil Beam Scanning Proton Therapy for Pediatric Parameningeal Rhabdomyosarcomas: Clinical Outcome of Patients Treated at the Paul Scherrer Institute.
    Weber DC; Ares C; Albertini F; Frei-Welte M; Niggli FK; Schneider R; Lomax AJ
    Pediatr Blood Cancer; 2016 Oct; 63(10):1731-6. PubMed ID: 26701148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton beam therapy for hepatocellular carcinoma.
    Yeung RH; Chapman TR; Bowen SR; Apisarnthanarax S
    Expert Rev Anticancer Ther; 2017 Oct; 17(10):911-924. PubMed ID: 28825506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A dosimetric comparison of proton and intensity modulated radiation therapy in pediatric rhabdomyosarcoma patients enrolled on a prospective phase II proton study.
    Ladra MM; Edgington SK; Mahajan A; Grosshans D; Szymonifka J; Khan F; Moteabbed M; Friedmann AM; MacDonald SM; Tarbell NJ; Yock TI
    Radiother Oncol; 2014 Oct; 113(1):77-83. PubMed ID: 25443861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.